TipRanks
Advertisement
Advertisement
Tandem Diabetes initiated with an Outperform at William Blair
PremiumThe FlyTandem Diabetes initiated with an Outperform at William Blair
2M ago
Tandem Diabetes price target raised to $24 from $21 at Citi
Premium
The Fly
Tandem Diabetes price target raised to $24 from $21 at Citi
2M ago
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
Premium
Ratings
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
2M ago
Analyst Reiterates Buy on Tandem, Citing Building Momentum Ahead of Mobi Tubeless Launch and Improving Margins
PremiumRatingsAnalyst Reiterates Buy on Tandem, Citing Building Momentum Ahead of Mobi Tubeless Launch and Improving Margins
2M ago
Tandem Diabetes reports Q2 EPS (31c), consensus (32c)
Premium
The Fly
Tandem Diabetes reports Q2 EPS (31c), consensus (32c)
2M ago
Tandem Diabetes sees FY26 revenue $1.065B-$1.085B, consensus $1.08B
Premium
The Fly
Tandem Diabetes sees FY26 revenue $1.065B-$1.085B, consensus $1.08B
2M ago
Insulet price target lowered to $245 from $280 at RBC Capital
PremiumThe FlyInsulet price target lowered to $245 from $280 at RBC Capital
3M ago
Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle
Premium
The Fly
Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle
3M ago
Tandem Diabetes initiated with a Hold at Deutsche Bank
Premium
The Fly
Tandem Diabetes initiated with a Hold at Deutsche Bank
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―